One NIH-funded postdoctoral position is immediately available in the laboratory of Dr. Antonio Di Cristofano at the Albert Einstein College of Medicine, Bronx, New York.
Our laboratory uses the thyroid gland as a model system to:
• Identify and deconstruct signaling cascades altered during neoplastic transformation
• Define signaling nodes where cooperating pathways intersect to drive transformation
• Design and test in vivo innovative, rationally designed therapeutic approaches for advanced thyroid cancer
Available projects for this position include:
• Characterization of novel, AKT-independent pathways that are activated downstream of PI3K
• Identification of druggable signaling nodes in RAS-driven tumors
• Design and testing of innovative pro-apoptotic therapeutic
Qualified individuals must possess:
• a strong background in molecular/cell biology and in signal transduction
• experience in the analysis of mouse models
• a record of achievements through peer-reviewed first-author publications in at least one of the two research areas described above (signal transduction and/or pre-clinical therapy)
Ability to work independently in a highly competitive environment, demonstrated creativity, and especially very high motivation are expected.
For representative examples of current research, see Wong, Endocr. Relat. Cancer, 2019; De Martino, Cancer Lett. 2018; Orlacchio, Cancer Res., 2017; Champa, Oncotarget, 2016.
Qualified applicants are invited to submit a CV and a brief statement describing background, future goals and reasons for the interest in this position. In addition, they must send names and contact info of two references to:
Dr. Antonio Di Cristofano, PhD, Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, 1301 Morris Park Avenue, Room 302 – Bronx, NY 10461.
IMPORTANT: write “Postdoc-2020” in the subject line of your email application.*
Our laboratory is in the Department of Developmental and Molecular Biology at the Albert Einstein College of Medicine in New York City.
We are one of the nation’s premier institutions for medical education, basic research and clinical investigation. It is home to some 2,000 faculty members, 750 M.D. students, 350 Ph.D. students attending the Sue Golding Graduate Division-including 125 in the combined M.D/Ph.D. program-and 325 postdoctoral investigators training at our Belfer Institute for Advanced Biomedical Studies. More than 7,000 Einstein Alumni are among the nation’s foremost clinicians, biomedical scientists and medical educators.
Long a national leader in biomedical research support from the Federal government, Einstein received $178 million in funding from the National Institutes of Health during 2019. This includes the funding for major research centers at Einstein in aging, intellectual development disorders, diabetes, cancer, clinical and translational research, liver disease and AIDS. Other areas of focus include developmental brain research, neuroscience, cardiac disease and other initiatives to reduce and eliminate ethnic and racial health disparities.
We have also been recognized by Forbes as one of the country’s best midsize employers in 2019. Forbes ranked Einstein in the top overall nationally among midsize employers. Einstein ranked 3rd within the education category in New York State and 9th nationally among all midsize education employers.
The Albert Einstein College of Medicine is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, protected veteran or disabled status, or genetic information. Einstein seeks candidates whose skills, and personal and professional experience, have prepared them to contribute to our commitment to diversity and excellence, and the communities we serve.